Moody's Says Sale of BeneVir Biopharm and tack-on note issuance are credit positive for HC2; no ratings impact
For the full text of this story please click the following link: http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_383228&WT.mc_id=AM~UmV1dGVyc05ld3MyX1NCX0NWX1JhdGluZ19OZXdzX0FsbA==~20180503_PR_383228
Recent news on DBM Global
See all newsBrief: DBM Global Inc. Announces Election Of Mark Koolis As CFO
Brief: Dbm Global Companies -- Banker Steel And Nyc Constructors -- Celebrate The “Topping Out” At The New Jpmorgan Chase Headquarters
Brief: Dbm Global Inc. Announces Addition Of Stacy Reyan To The Board Of Directors
Brief: DBM Global Inc Announces Addition Of Robert B. Holland, III To The Board Of Directors
Brief: DBM Global Announces Additions To Board Of Directors